SAN DIEGO – Hempacco Co, Inc. (NASDAQ: HPCO), a known player in the nutraceutical industry, has taken a significant step to enhance its manufacturing capabilities and customer reach by acquiring a portion of the assets of Covalent CBD, a leader in white-label and private label nutraceuticals. This move is expected to strengthen Hempacco's position in the growing hemp and mushroom supplement sectors.
Covalent CBD's reputation for a broad client base and a robust procurement network in the nutritional supplement market, particularly within the hemp industry, positions Hempacco to broaden its service offerings. The acquisition is aimed at expanding Hempacco’s production capacity, client network, and supplier base, which could potentially accelerate the company's growth and innovation within the nutraceutical space.
Sandro Piancone, CEO of Hempacco, commented on the acquisition, "This acquisition should be a game-changer for Hempacco, allowing us to leapfrog our capabilities in hemp and mushroom product manufacturing." The integration of Covalent CBD's assets is anticipated to not only expand Hempacco's production but also to enhance sales and supplier networks.
Kelly Ann Lewis-Bortman, President of Covalent, expressed enthusiasm about the partnership, stating, "Our combined strengths in innovation, manufacturing, and customer service will enable us to deliver unparalleled value to our clients and set new standards in the industry."
The acquisition will enable Hempacco to offer white-label and private label R&D and manufacturing, specializing in intellectual property-driven projects. These include mushroom extraction using water and magnets, beverage and shot R&D, gummy production with various cannabinoids, and manufacturing of pills, capsules, tinctures, and other nutraceuticals using Hempacco's intellectual property. Additionally, the production of Hemp Blunts smoking paper is included in the acquisition.
Hempacco's portfolio includes the manufacturing of smokables, hemp rolling paper, and cannabinoid sticks, as well as the development of smokable technology. The company also owns The Real Stuff™ brand of functional smokables and rolling paper and has partnerships with notable personalities such as Cheech and Chong, Rick Ross, and Snoop Dogg for hemp-derived products.
The information reported is based on a press release statement.
InvestingPro Insights
In light of Hempacco Co, Inc.'s recent acquisition of Covalent CBD's assets, investors are closely monitoring the company's financial health and market performance. Despite the potential for growth in the nutraceutical industry, Hempacco faces several challenges that are reflected in its financial metrics and market data.
According to InvestingPro data, Hempacco's market capitalization stands at a modest 7.51 million USD, suggesting a relatively small size within the market. The company's P/E ratio, both standard and adjusted for the last twelve months as of Q3 2023, is negative at -0.562 and -1.05 respectively, indicating that investors are not currently expecting earnings growth. Moreover, Hempacco's revenue has seen a significant decline of approximately 31.79% over the last twelve months as of Q3 2023, which raises concerns about the company's ability to grow sales.
InvestingPro Tips highlight several areas of concern for Hempacco. The company is quickly burning through cash and may have trouble making interest payments on its debt. Additionally, it suffers from weak gross profit margins, with a gross profit margin of -44.07% over the last twelve months as of Q3 2023. This is indicative of the company's struggle to turn revenues into profit. Furthermore, Hempacco's short-term obligations exceed its liquid assets, which could pose a risk to its financial stability.
Investors considering Hempacco as an investment opportunity may want to explore further insights. InvestingPro offers additional tips for a comprehensive analysis, including valuation implications and stock performance history. For instance, Hempacco's stock has experienced a notable decline over various periods, with a one-year price total return of -61.45% as of the latest data. These insights can be critical for making informed investment decisions.
To access a full range of InvestingPro Tips for Hempacco, which can provide a deeper understanding of the company's financial and market position, visit the dedicated page at https://www.investing.com/pro/HPCO. For those interested in an annual or biannual Pro and Pro+ subscription, use the coupon code PRONEWS24 to receive an additional 10% off. The platform lists a total of 12 additional tips that can further inform investment strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.